| Jul 25 |
argenx SE (ARGX) Q2 2024 Earnings Call Transcript
|
| Jul 25 |
argenx SE 2024 Q2 - Results - Earnings Call Presentation
|
| Jul 25 |
argenx SE beats top-line and bottom-line estimates; updates FY24 outlook
|
| Jul 25 |
argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
|
| Jul 24 |
Argenx SE 1H Earnings Preview
|
| Jul 24 |
Oppenheimer upgrades Argenx to outperform, cites Vyvgart Hytrulo
|
| Jul 18 |
argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
|
| Jul 16 |
What Made argenx SE (ARGX) Rise in Q2?
|
| Jul 16 |
argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
|
| Jul 16 |
Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
|
